| Literature DB >> 35241093 |
Marcin Morawski1, Michał Grąt2, Maciej Krasnodębski2, Konrad Kobryń2, Wacław Hołówko2, Paweł Rykowski2, Marta Dec3, Małgorzata Nowosad2, Wojciech Figiel2, Waldemar Patkowski2, Krzysztof Zieniewicz2.
Abstract
BACKGROUND: Laparoscopic liver resections offer potential benefits but may require advanced laparoscopic skills and are volume dependent.Entities:
Keywords: Complications; Laparoscopy; Liver resection
Mesh:
Year: 2022 PMID: 35241093 PMCID: PMC8892810 DOI: 10.1186/s12957-022-02505-5
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1Liver resection in the cirrhotic patient with combined hepatocellular-cholangiocarcinoma. Identification of A right hepatic artery and B right portal vein branch. C Mobilized right liver lobe and D transection line
Fig. 2Computed tomography of the cirrhotic patient with combined hepatocellular-cholangiocarcinoma. (*) Tumor thrombus in the right portal vein branch
Fig. 3Magnetic resonance imaging of the patient with large adenoma
Baseline characteristics of the study group and comparison of laparoscopic and open liver resection groups
| Variables | Number (%) or median (IQR) | Laparoscopic liver resection | Open liver resection | |
|---|---|---|---|---|
| Sex | 0.173 | |||
| Male | 14 (38.9%) | 7 (58.3%) | 7 (29.2%) | |
| Female | 22 (61.1%) | 5 (41.7%) | 17 (70.8%) | |
| 65 (53–69) | 61 (45–68) | 65 (54–67) | 0.208 | |
| 18 (50.0%) | 5 (41.7%) | 13 (54.2%) | 0.725 | |
| Right hemihepatectomy | 22 (61.1%) | 6 (50%) | 16 (66.7%) | |
| Right extended hemihepatectomy | 7 (19.4%) | 4 (33.3%) | 3 (12.5%) | |
| Left hemihepatectomy | 5 (13.9%) | 2 (16.7%) | 3 (12.5%) | |
| Left extended hemihepatectomy | 2 (5.6%) | 2 (8.3%) | ||
| Colorectal metastases | 20 (55.6%) | 7 (58.3%) | 13 (54.2%) | |
| Hepatocellular carcinoma | 3 (8.3%) | 3 (12.5%) | ||
| Cholangiocarcinoma | 6 (16.7%) | 1 (8.3%) | 5 (20.8%) | |
| Other | 7 (19.4%) | 4 (33.3%) | 3 (12.5%) | |
| 7 (19.4%) | 2 (16.7%) | 5 (20.3%) | 1.000 | |
| Cholecystectomy | 26 (72.2%) | 10 (83.3%) | 16 (66.7%) | 0.510 |
| Lymphadenectomy | 4 (16.7%) | |||
| Diaphragm resection | 4 (16.7%) | |||
| Extrahepatic bile ducts resection with Roux-en-Y anastomosis | 2 (8.3%) | |||
| 1 (1–2) | 1 (1–3) | 1 (1–2) | 0.772 | |
| 45 (30–75) | 41 (25–61) | 45 (33–80) | 0.548 | |
| 1 (2.78%) | 1 (8.33%) | 0 (0%) | 0.333 | |
| White Blood Cell (103/L) | 6.43 (5.07–7.67) | 6.43 (4.72–8.03) | 6.45 (5.24–7.56) | 0.933 |
| Hemoglobin (g/dL) | 13.1 (12.0–14.1) | 13.0 (12.0–15.1) | 13.1 (12.1–13.7) | 0.523 |
| Platelets (103/μL) | 213 (189–276) | 208 (194–268) | 222 (185–276) | 0.788 |
| Bilirubin (mg/dL) | 0.44 (0.33–0.77) | 0.51 (0.31–0.86) | 0.44 (0.35–0.73) | 0.933 |
| Albumin (g/dL) | 4.4 (4.0–4.7) | 4.3 (4.1–4.7) | 4.5 (4.0–4.7) | 0.853 |
| INR | 1.03 (0.97–1.07) | 1.04 (0.98–1.09) | 1.01 (0.96–1.07) | 0.449 |
| Creatinine (mg/dL) | 0.76 (0.68–0.88) | 0.76 (0.64–0.87) | 0.80 (0.70–0.91) | 0.603 |
| Aspartate aminotransferase (IU/L) | 31 (24–41) | 25 (22–34) | 36 (27–44) | 0.090 |
| Alanine aminotransferase (IU/L) | 27 (20–47) | 23 (19–37) | 29 (21–49) | 0.364 |
| 270 (240–540) | 600 (540–690) | 240 (210–285) | < 0.05* | |
Summary of details on postoperative hospital stay and complications according to Clavien-Dindo
| Number (%) or median (IQR) | Laparoscopic liver resection | Open liver resection | ||
|---|---|---|---|---|
| Postoperative hospital stay (days) | 7 (6–12) | 6 (6–8) | 8 (7–14) | 0.046* |
| White blood cell (103/L) | 7.03 (5.19–8.78) | 7.18 (5.34–8.76) | 6.37 (5.00–9.09) | 0.934 |
| Hemoglobin (g/dL) | 10.1 (9.4–11.0) | 10.0 (9.5–12.2) | 10.2 (9.3–10.6) | 0.804 |
| Bilirubin (mg/dL) | 0.89 (0.63–1.44) | 1.06 (0.85–1.44) | 0.80 (0.52–1.41) | 0.120 |
| INR | 1.16 (1.04–1.30) | 1.07 (1.02–1.22) | 1.21 (1.06–1.33) | 0.146 |
| Creatinine (mg/dL) | 0.75 (0.63–1.10) | 0.76 (0.66–0.88) | 0.75 (0.61–1.17) | 0.908 |
| Aspartate aminotransferase (IU/L) | 114 (85–206) | 179 (121–238) | 101 (72–148) | 0.029* |
| Alanine aminotransferase (IU/L) | 220 (157–431) | 346 (192–446) | 189 (132–348) | 0.090 |
| 350 (300–400) | ||||
| 7 (19.4%) | 1 (8.3%) | 6 (25%) | 0.234 | |
| 3 (8.3%) | 2 (16.7%) | 1 (4.2%) | 0.253 | |
| Grade I | ||||
| Prolonged abdominal drainage | 3 | 5 | ||
| Surgical site infection | 4 | |||
| Grade II | ||||
| Blood transfusion | 1 | 3 | ||
| Intravenous antibiotics | 6 | |||
| Total parenteral nutrition | 1 | 2 | ||
| Grade IIIa | ||||
| Pleurocentesis | 1 | |||
| Grade IIIb | ||||
| Biliary fistula | 1 | 1 | ||
| Surgical site infection | 1 | |||
| Hemorrhage | 1 | |||
| Intestinal perforation | 2 | |||
| Grade IV | ||||
| Portal vein thrombosis | 1 | |||
| Acute kidney injury (dialysis) | 1 | |||
| Grade V | 1 | |||
| 0 (0–8.7) | 20.9 (0–36.0) | 0.039* | ||
*Only patients with malignant liver tumors